Martin, Keith R.
The University of Melbourne · Wellcome/MRC Cambridge Stem Cell Institute · University of Cambridge · The Royal Victorian Eye & Ear Hospital · Centre for Eye Research Australia
10 papers on CoChatORCID 0000-0002-9347-3661
Most cited papers
- Verified
Gene therapy with brain-derived neurotrophic factor as a protection: Retinal ganglion cells in a rat glaucoma model
Martin, K. R. G., Quigley, H. A., Zack, D. J., Levkovitch-Verbin, H., Kielczewski, J., Valenta, D., Baumrind, L., Pease, M. E., Klein, R. L., & Hauswirth, W. W. (2003) · Investigative Opthalmology & Visual Science
Glaucoma and retinal disordersVirus-based gene therapy research
Cited by 362
- Verified
Improvement in inner retinal function in glaucoma with nicotinamide (vitamin B3 ) supplementation: A crossover randomized clinical trial
Hui, F., Tang, J., Williams, P. A., McGuinness, M. B., Hadoux, X., Casson, R. J., Coote, M., Trounce, I. A., Martin, K. R., van Wijngaarden, P., et al. (2020) · Clinical & Experimental Ophthalmology
Glaucoma and retinal disordersRetinal Diseases and Treatments
Cited by 226
- Verified
Neuroprotection of retinal ganglion cells by a novel gene therapy construct that achieves sustained enhancement of brain-derived neurotrophic factor/tropomyosin-related kinase receptor-B signaling
Osborne, A., Khatib, T. Z., Songra, L., Barber, A. C., Hall, K., Kong, G. Y. X., Widdowson, P. S., & Martin, K. R. (2018) · Cell Death & Disease
Glaucoma and retinal disordersVirus-based gene therapy research
Cited by 175
- Verified
Gene delivery to the eye using adeno-associated viral vectors
Martin, K. R. G., Klein, R. L., & Quigley, H. A. (2002) · Methods
Virus-based gene therapy researchRetinal Development and Disorders
Cited by 149
- Verified · note
Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability
Gasparini, L., Anthony Crowther, R., Martin, K. R., Berg, N., Coleman, M., Goedert, M., & Spillantini, M. G. (2011) · Neurobiology of Aging
Alzheimer's disease research and treatmentsGlaucoma and retinal disorders
Cited by 133
- Verified
Identification of a critical sulfation in chondroitin that inhibits axonal regeneration
Pearson, C. S., Mencio, C. P., Barber, A. C., Martin, K. R., & Geller, H. M. (2018) · eLife
Nerve injury and regenerationProteoglycans and glycosaminoglycans research
Cited by 75
- Verified
Humoral immune responses to AAV gene therapy in the ocular compartment
Whitehead, M., Osborne, A., Yu‐Wai‐Man, P., & Martin, K. (2021) · Biological Reviews
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 52
- Verified
RNA-targeting strategies as a platform for ocular gene therapy
Kumar, S., Fry, L. E., Wang, J.-H., Martin, K. R., Hewitt, A. W., Chen, F. K., & Liu, G.-S. (2023) · Progress in Retinal and Eye Research
RNA Interference and Gene DeliveryRetinal Development and Disorders
Cited by 51
- Verified
Age-related Macular Degeneration and Modification of Systemic Complement Factor H Production Through Liver Transplantation
Khandhadia, S., Hakobyan, S., Heng, L. Z., Gibson, J., Adams, D. H., Alexander, G. J., Gibson, J. M., Martin, K. R., Menon, G., Nash, K., et al. (2013) · Ophthalmology
Retinal Diseases and TreatmentsComplement system in diseases
Cited by 47
- Verified
Design of a Novel Gene Therapy Construct to Achieve Sustained Brain-Derived Neurotrophic Factor Signaling in Neurons
Osborne, A., Wang, A. X. Z., Tassoni, A., Widdowson, P. S., & Martin, K. R. (2018) · Human Gene Therapy
Virus-based gene therapy researchNerve injury and regeneration
Cited by 43
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free